Stable oral formulation containing 1-(3-cyano-1-isopropyl-indol-5-YL)pyrazole-4-carboxylic acid

MYPI2025000869A0Undetermined Publication Date: 2022-06-01LG CHEM LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025000869
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-12-01
Filing Date
2021-11-30
Publication Date
2022-06-01
Patent Text Reader

Abstract

STABLE ORAL FORMULATION CONTAINING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID 【ABSTRACT】 The present invention relates to a stable oral formulation comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazol-4-carboxylic acid or a pharma-ceutically acceptable salt thereof as an API. The stable oral formulation according to the present invention has the characteristics of maintaining stability even if it does not comprise a stabilizer as an excipient, and does not comprise a stabilizer but has increased API content, and thus the convenience of administration can be increased.
Need to check novelty before this filing date? Find Prior Art